[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Cheung et al., 1991 - Google Patents

The role of the epidermal growth factor-1 and hydrophobic stack domains of human factor IX in binding to endothelial cells

Cheung et al., 1991

View PDF
Document ID
16469111411045047
Author
Cheung W
Straight D
Smith K
Lin S
Roberts H
Stafford D
Publication year
Publication venue
Journal of Biological Chemistry

External Links

Snippet

To determine the function and specificity in factor IX of the first epidermal growth factor (EGF)- like domain and the eight-amino acid hydrophobic stack encoded by exon C (residues 39- 46), these domains were replaced by the corresponding polypeptide regions of factor X and …
Continue reading at www.jbc.org (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Similar Documents

Publication Publication Date Title
Gailani et al. Model for a factor IX activation complex on blood platelets: dimeric conformation of factor XIa is essential
Broze et al. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action
US5504064A (en) Treatment of bleeding with modified tissue factor in combination with an activator of FVII
O'Brien et al. Purification and characterization of factor VII 304-Gln: a variant molecule with reduced activity isolated from a clinically unaffected male
Toomey et al. Localization of the human tissue factor recognition determinant of human factor VIIa.
CN108289851B (en) Long-acting coagulation factor and production method thereof
Rezaie et al. Analysis of the functions of the first epidermal growth factor-like domain of factor X.
Chaing et al. Severe factor VII deficiency caused by mutations abolishing the cleavage site for activation and altering binding to tissue factor
JP4986618B2 (en) Activated protein C variant with normal cytoprotective activity but reduced anticoagulant activity
Ware et al. Factor IX San Dimas: Substitution of glutamine for arg− 4 in the propeptide leads to incomplete γ-carboxylation and altered phospholipid binding properties
Matsuoka et al. Plasminogen-mediated activation and release of hepatocyte growth factor from extracellular matrix
JP2559537B2 (en) Monoclonal antibody against protein C
Cheung et al. The role of the epidermal growth factor-1 and hydrophobic stack domains of human factor IX in binding to endothelial cells
JP2010508031A (en) Activated protein C variant with normal cytoprotective activity but reduced anticoagulant activity
JP3270462B2 (en) Hybrid protein C
Runge et al. Plasminogen activators. The old and the new.
Chang et al. The roles of factor VII's structural domains in tissue factor binding
Christophe et al. Functional mapping of anti–factor IX inhibitors developed in patients with severe hemophilia B
Astermark et al. The epidermal growth factor-like domains of factor IX. Effect on blood clotting and endothelial cell binding of a fragment containing the epidermal growth factor-like domains linked to the gamma-carboxyglutamic acid region
Koppelman et al. Synergistic inhibition of the intrinsic factor X activation by protein S and C4b-binding protein
US6624289B1 (en) Region of factor IXa protease domain that interacts with factor VIIIa and methods therefor
CN1934252B (en) Thrombin derivatives and pharmaceutical compositions containing said thrombin derivatives
Grieninger Contribution of the αEC Domain to the Structure and Function of Fibrinogen‐420
US7109170B2 (en) Region of factor IXa protease domain that interacts with factor VIIIa and methods therefor
AU2004272731A1 (en) Plasminogen activators having reduced lysine binding capacity